<DOC>
	<DOCNO>NCT00415025</DOCNO>
	<brief_summary>RATIONALE : Tests measure much saliva make , hearing , swallow , voice function , quality life may improve ability plan treatment patient advanced head neck cancer may help doctor find good way treat cancer . PURPOSE : This clinical trial study side effect high-dose intensity-modulated radiation therapy treat patient advanced head neck cancer .</brief_summary>
	<brief_title>Side Effects High-Dose Intensity-Modulated Radiation Therapy Treating Patients With Advanced Head Neck Cancer</brief_title>
	<detailed_description>OBJECTIVES : Primary - Assess salivary function patient advanced head neck cancer treat intensity-modulated radiotherapy ( IMRT ) measure stimulate saliva production 6 12 month completion therapy . - Compare salivary function patient salivary function historical control . Secondary - Assess auditory , swallow , voice function quality life patient IMRT chemoradiotherapy . - Advance experience IMRT/tomotherapy improve field design irradiate head neck cancer effort reduce radiation dose minimize effect surround normal tissue . OUTLINE : This prospective study . Patients undergo standard care high-dose intensity-modulated radiotherapy ( IMRT ) head neck . Patients undergo baseline post-treatment test auditory , salivary , swallow , voice function well quality life evaluation . Patients evaluate radiation-induced toxicity 1 , 6 , 12 month completion IMRT . PROJECTED ACCRUAL : A total 20 patient accrue study .</detailed_description>
	<mesh_term>Head Neck Neoplasms</mesh_term>
	<mesh_term>Radiation Injuries</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically confirm advanced head neck cancer Indication radiotherapy chemoradiotherapy primary postoperative therapy AND meet 1 follow criterion : More 75 % bilateral parotid gland expect receive â‰¥ 45 cGy radiation use conventional treatment field design Either central auditory apparatus predict receive &gt; 45 cGy radiation PATIENT CHARACTERISTICS : No comorbid medical condition would preclude radiotherapy No serious concurrent psychosocial , familial , sociological , geographical , condition would preclude study compliance PRIOR CONCURRENT THERAPY : See Disease Characteristics</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>120 Years</maximum_age>
	<verification_date>October 2015</verification_date>
	<keyword>long-term effect secondary cancer therapy adult</keyword>
	<keyword>oral complication radiation therapy</keyword>
	<keyword>radiation toxicity</keyword>
	<keyword>stage III squamous cell carcinoma hypopharynx</keyword>
	<keyword>stage IV squamous cell carcinoma hypopharynx</keyword>
	<keyword>stage III squamous cell carcinoma larynx</keyword>
	<keyword>stage III verrucous carcinoma larynx</keyword>
	<keyword>stage IV squamous cell carcinoma larynx</keyword>
	<keyword>stage IV verrucous carcinoma larynx</keyword>
	<keyword>stage III lymphoepithelioma oropharynx</keyword>
	<keyword>stage III squamous cell carcinoma oropharynx</keyword>
	<keyword>stage IV lymphoepithelioma oropharynx</keyword>
	<keyword>stage IV squamous cell carcinoma oropharynx</keyword>
	<keyword>stage III basal cell carcinoma lip</keyword>
	<keyword>stage III squamous cell carcinoma lip oral cavity</keyword>
	<keyword>stage IV basal cell carcinoma lip</keyword>
	<keyword>stage IV squamous cell carcinoma lip oral cavity</keyword>
	<keyword>stage III adenoid cystic carcinoma oral cavity</keyword>
	<keyword>stage III mucoepidermoid carcinoma oral cavity</keyword>
	<keyword>stage III verrucous carcinoma oral cavity</keyword>
	<keyword>stage IV adenoid cystic carcinoma oral cavity</keyword>
	<keyword>stage IV mucoepidermoid carcinoma oral cavity</keyword>
	<keyword>stage IV verrucous carcinoma oral cavity</keyword>
	<keyword>metastatic squamous neck cancer occult primary</keyword>
	<keyword>stage III lymphoepithelioma nasopharynx</keyword>
	<keyword>stage III squamous cell carcinoma nasopharynx</keyword>
	<keyword>stage IV lymphoepithelioma nasopharynx</keyword>
	<keyword>stage IV squamous cell carcinoma nasopharynx</keyword>
	<keyword>stage III esthesioneuroblastoma paranasal sinus nasal cavity</keyword>
	<keyword>stage III invert papilloma paranasal sinus nasal cavity</keyword>
	<keyword>stage III midline lethal granuloma paranasal sinus nasal cavity</keyword>
	<keyword>stage III squamous cell carcinoma paranasal sinus nasal cavity</keyword>
	<keyword>stage IV esthesioneuroblastoma paranasal sinus nasal cavity</keyword>
	<keyword>stage IV invert papilloma paranasal sinus nasal cavity</keyword>
	<keyword>stage IV midline lethal granuloma paranasal sinus nasal cavity</keyword>
	<keyword>stage IV squamous cell carcinoma paranasal sinus nasal cavity</keyword>
	<keyword>stage III salivary gland cancer</keyword>
	<keyword>stage IV salivary gland cancer</keyword>
	<keyword>recurrent salivary gland cancer</keyword>
	<keyword>recurrent lymphoepithelioma nasopharynx</keyword>
	<keyword>recurrent lymphoepithelioma oropharynx</keyword>
	<keyword>recurrent squamous cell carcinoma hypopharynx</keyword>
	<keyword>recurrent squamous cell carcinoma larynx</keyword>
	<keyword>recurrent squamous cell carcinoma nasopharynx</keyword>
	<keyword>recurrent squamous cell carcinoma oropharynx</keyword>
	<keyword>recurrent verrucous carcinoma larynx</keyword>
	<keyword>recurrent adenoid cystic carcinoma oral cavity</keyword>
	<keyword>recurrent mucoepidermoid carcinoma oral cavity</keyword>
	<keyword>recurrent verrucous carcinoma oral cavity</keyword>
	<keyword>recurrent esthesioneuroblastoma paranasal sinus nasal cavity</keyword>
	<keyword>recurrent invert papilloma paranasal sinus nasal cavity</keyword>
	<keyword>recurrent midline lethal granuloma paranasal sinus nasal cavity</keyword>
	<keyword>recurrent squamous cell carcinoma paranasal sinus nasal cavity</keyword>
	<keyword>recurrent basal cell carcinoma lip</keyword>
	<keyword>recurrent squamous cell carcinoma lip oral cavity</keyword>
	<keyword>recurrent metastatic squamous neck cancer occult primary</keyword>
	<keyword>untreated metastatic squamous neck cancer occult primary</keyword>
</DOC>